Division of Endocrinology, Gerontology and Metabolism, Stanford University School of Medicine, Stanford, California, USA.
J Intern Med. 2024 Jun;295(6):735-747. doi: 10.1111/joim.13786. Epub 2024 Apr 12.
Prediabetes is an intermediate state of glucose homeostasis whereby plasma glucose concentrations are above normal but below the threshold of diagnosis for diabetes. Over the last several decades, criteria for prediabetes have changed as the cut points for normal glucose concentration and diagnosis of diabetes have shifted. Global consensus does not exist for prediabetes criteria; as a result, the clinical course and risk for type 2 diabetes vary. At present, we can identify individuals with prediabetes based on three glycemic tests (hemoglobin A1c, fasting plasma glucose, and 2-h plasma glucose during an oral glucose tolerance test). The majority of individuals diagnosed with prediabetes meet only one of these criteria. Meeting one, two, or all glycemic criteria changes risk for type 2 diabetes, but this information is not widely known and does not currently guide intervention strategies for individuals with prediabetes. This review summarizes current epidemiology, prognosis, and intervention strategies for individuals diagnosed with prediabetes and suggests a call for more precise risk stratification of individuals with prediabetes as elevated (one prediabetes criterion), high risk (two prediabetes criteria), and very high risk (three prediabetes criteria). In addition, the roles of oral glucose tolerance testing and continuous glucose monitoring in the diagnostic criteria for prediabetes need reassessment. Finally, we must reframe our goals for prediabetes and prioritize intensive interventions for those at high and very high risk for type 2 diabetes.
糖尿病前期是葡萄糖稳态的中间状态,此时血浆葡萄糖浓度高于正常但低于糖尿病的诊断阈值。在过去的几十年中,由于正常葡萄糖浓度和糖尿病诊断的切点发生了变化,糖尿病前期的标准也发生了变化。全球对于糖尿病前期标准没有达成共识;因此,2 型糖尿病的临床病程和风险各不相同。目前,我们可以根据三种血糖测试(糖化血红蛋白、空腹血浆葡萄糖和口服葡萄糖耐量试验期间的 2 小时血浆葡萄糖)来识别糖尿病前期患者。大多数被诊断为糖尿病前期的患者仅符合其中一项标准。符合一项、两项或所有血糖标准都会改变 2 型糖尿病的风险,但这方面的信息尚未广泛普及,目前也不会指导糖尿病前期患者的干预策略。本综述总结了目前诊断为糖尿病前期的个体的流行病学、预后和干预策略,并呼吁对糖尿病前期个体进行更精确的风险分层,包括升高(一项糖尿病前期标准)、高风险(两项糖尿病前期标准)和极高风险(三项糖尿病前期标准)。此外,需要重新评估口服葡萄糖耐量试验和连续血糖监测在糖尿病前期诊断标准中的作用。最后,我们必须重新调整糖尿病前期的目标,并为高风险和极高风险的 2 型糖尿病患者提供强化干预措施。